Inventor · disambiguated record
James Zapf
Also filed as: ZAPF JAMES · ZAPF JAMES W
6 granted patents·11 pending applications·22 citations·filing 2002–2024
80Inventor score
Files withDART NEUROSCIENCE CAYMAN LTD5DART NEUROSCIENCE LLC3ORTHO MCNEIL PHARM INC2PFAHL MAGNUS2ALTANA PHARMA AG1
Top patents by PatentIndex Score
17 records- 0187US2025122172A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0281US9120770B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Sep 1, 2015·3 cites·30 claims
- 0379US2023075774A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 0478US9040692B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted May 26, 2015·2 cites·1 claims
- 0578US7102000B2Heterocyclic amide derivatives for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2003·Granted Sep 5, 2006·9 cites·77 claims
- 0674US9573937B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Feb 21, 2017·1 cites·20 claims
- 0773US11279691B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE LLC·Filed 2019·Granted Mar 22, 2022·0 cites·4 claims
- 0871US7196108B2Bicyclic heterocycles for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2003·Granted Mar 27, 2007·7 cites·61 claims
- 0965US2018346448A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Application pending·0 cites
- 1064US2016009691A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Application pending·0 cites
- 1153US2008199480A1Methods for Identifying Risk of Type II Diabetes and Treatments ThereofSEQUENOM INC·Filed 2004·Application pending·0 cites
- 1248US2006241138A1Heterocyclic amide derivatives for the treatment of diabetes and other diseasesPFAHL MAGNUS·Filed 2006·Application pending·0 cites
- 1347US2005209286A1RXR activating moleculesPFAHL MAGNUS·Filed 2005·Application pending·0 cites
- 1442US2005222186A1Substituted diaminopyrimidinesALTANA PHARMA AG·Filed 2003·Application pending·0 cites
- 1542US2005038098A1Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseasesFiled 2004·Application pending·0 cites
- 1638US2004097566A12-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancerFiled 2002·Application pending·0 cites
- 1738US2005014767A1Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseasesFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Zapf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →